PortfoliosLab logo
GMAB vs. SANM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GMAB and SANM is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

GMAB vs. SANM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Genmab A/S (GMAB) and Sanmina Corporation (SANM). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

GMAB:

-0.76

SANM:

0.63

Sortino Ratio

GMAB:

-0.90

SANM:

1.17

Omega Ratio

GMAB:

0.88

SANM:

1.15

Calmar Ratio

GMAB:

-0.40

SANM:

0.31

Martin Ratio

GMAB:

-1.11

SANM:

2.68

Ulcer Index

GMAB:

22.65%

SANM:

9.43%

Daily Std Dev

GMAB:

33.26%

SANM:

37.46%

Max Drawdown

GMAB:

-84.20%

SANM:

-99.66%

Current Drawdown

GMAB:

-57.00%

SANM:

-76.08%

Fundamentals

Market Cap

GMAB:

$13.13B

SANM:

$4.53B

EPS

GMAB:

$1.71

SANM:

$4.32

PE Ratio

GMAB:

12.47

SANM:

19.60

PEG Ratio

GMAB:

1.12

SANM:

0.96

PS Ratio

GMAB:

4.06

SANM:

0.58

PB Ratio

GMAB:

2.48

SANM:

2.02

Total Revenue (TTM)

GMAB:

$18.10B

SANM:

$7.85B

Gross Profit (TTM)

GMAB:

$17.26B

SANM:

$668.98M

EBITDA (TTM)

GMAB:

$6.62B

SANM:

$482.12M

Returns By Period

In the year-to-date period, GMAB achieves a 0.38% return, which is significantly lower than SANM's 11.92% return. Over the past 10 years, GMAB has underperformed SANM with an annualized return of 8.91%, while SANM has yielded a comparatively higher 14.71% annualized return.


GMAB

YTD

0.38%

1M

-0.95%

6M

-2.56%

1Y

-25.15%

3Y*

-11.53%

5Y*

-7.22%

10Y*

8.91%

SANM

YTD

11.92%

1M

10.29%

6M

6.65%

1Y

23.44%

3Y*

24.50%

5Y*

26.05%

10Y*

14.71%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Genmab A/S

Sanmina Corporation

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

GMAB vs. SANM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GMAB
The Risk-Adjusted Performance Rank of GMAB is 1717
Overall Rank
The Sharpe Ratio Rank of GMAB is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of GMAB is 1414
Sortino Ratio Rank
The Omega Ratio Rank of GMAB is 1414
Omega Ratio Rank
The Calmar Ratio Rank of GMAB is 2525
Calmar Ratio Rank
The Martin Ratio Rank of GMAB is 2121
Martin Ratio Rank

SANM
The Risk-Adjusted Performance Rank of SANM is 7070
Overall Rank
The Sharpe Ratio Rank of SANM is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of SANM is 6969
Sortino Ratio Rank
The Omega Ratio Rank of SANM is 6868
Omega Ratio Rank
The Calmar Ratio Rank of SANM is 6565
Calmar Ratio Rank
The Martin Ratio Rank of SANM is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GMAB vs. SANM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Genmab A/S (GMAB) and Sanmina Corporation (SANM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current GMAB Sharpe Ratio is -0.76, which is lower than the SANM Sharpe Ratio of 0.63. The chart below compares the historical Sharpe Ratios of GMAB and SANM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

GMAB vs. SANM - Dividend Comparison

Neither GMAB nor SANM has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

GMAB vs. SANM - Drawdown Comparison

The maximum GMAB drawdown since its inception was -84.20%, smaller than the maximum SANM drawdown of -99.66%. Use the drawdown chart below to compare losses from any high point for GMAB and SANM.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

GMAB vs. SANM - Volatility Comparison

Genmab A/S (GMAB) has a higher volatility of 11.31% compared to Sanmina Corporation (SANM) at 8.84%. This indicates that GMAB's price experiences larger fluctuations and is considered to be riskier than SANM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

GMAB vs. SANM - Financials Comparison

This section allows you to compare key financial metrics between Genmab A/S and Sanmina Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B2.00B3.00B4.00B5.00B6.00B20212022202320242025
715.00M
1.98B
(GMAB) Total Revenue
(SANM) Total Revenue
Values in USD except per share items

GMAB vs. SANM - Profitability Comparison

The chart below illustrates the profitability comparison between Genmab A/S and Sanmina Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%20212022202320242025
94.1%
8.9%
(GMAB) Gross Margin
(SANM) Gross Margin
GMAB - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Genmab A/S reported a gross profit of 673.00M and revenue of 715.00M. Therefore, the gross margin over that period was 94.1%.

SANM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Sanmina Corporation reported a gross profit of 176.24M and revenue of 1.98B. Therefore, the gross margin over that period was 8.9%.

GMAB - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Genmab A/S reported an operating income of 188.00M and revenue of 715.00M, resulting in an operating margin of 26.3%.

SANM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Sanmina Corporation reported an operating income of 91.62M and revenue of 1.98B, resulting in an operating margin of 4.6%.

GMAB - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Genmab A/S reported a net income of 195.00M and revenue of 715.00M, resulting in a net margin of 27.3%.

SANM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Sanmina Corporation reported a net income of 64.21M and revenue of 1.98B, resulting in a net margin of 3.2%.